Sign Up For Life Science Leader Magazine

THE CURRENT ISSUE

  • The Importance Of Reevaluating The Preferred Vendor List
    The Importance Of Reevaluating The Preferred Vendor List

    Biopharmaceutical companies with preferred provider lists should have an internal system to gather feedback throughout the course of the project and after its completion. However, internal feedback should not be the only basis for evaluation of companies on the preferred vendor list. 

  • A Combination of Functional And Full-Service CROs Supports Strategic Outsourcing
    A Combination of Functional And Full-Service CROs Supports Strategic Outsourcing

    Outsourcing has become part of the strategy of just about every business in the drug development industry. Subcontracting various procedures along the stages of development to outside firms adds value to the process by reducing fixed costs, shortening timelines, and offering access to external expertise.

  • The Continued Evolution Of The Sponsor-CRO Relationship
    The Continued Evolution Of The Sponsor-CRO Relationship

    Not long ago, the dynamic between the sponsor and the CRO was purely that of a client/vendor. Contract research organizations were engaged to reduce fixed labor costs on the sponsor side for work that varied in demand.

  • Use Data To Find And Manage Your CRO Partnerships
    Use Data To Find And Manage Your CRO Partnerships

    According to Hurd, there are currently 9 billion devices connected to the Internet, a number that may reach 50 billion by the end of the decade. This will create an absolute explosion of data that businesses, including those in the life sciences, will have to manage. We know going in that a lot of that data will be worthless. Therefore, it will be incumbent upon companies to discern the valuable data from the noise.

  • Big Data In Life Sciences: Trends, Challenges, And The Payoff
    Big Data In Life Sciences: Trends, Challenges, And The Payoff

    Information is playing a critical new role in the business of life sciences, from discovery to commercial operations. Big Data is a major agent of change in the trends, challenges, and payoffs for this emerging focus, and now is a good time for informatics and analytics professionals to step back and see where we are and where we can go.

  • The Strength At The Interface: Academia Meets Biopharma Industry
    The Strength At The Interface: Academia Meets Biopharma Industry

    Collaborations between academia and industry are becoming more common as biopharma companies, both large and small, see the value gained from different approaches.

  • 5 Management Strategies For Life Sciences Real Estate & Facilities
    5 Management Strategies For Life Sciences Real Estate & Facilities

    In a new paradigm of the life sciences industry, corporate real estate can be a source of top-line value.

More Magazine Articles....

LIFE SCIENCE TRAINING INSTITUTE

More From LSTI

 UPCOMING EVENTS

Medical Device Complaint Handling and MDR Reporting

September 3, 2014
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate

Identifying and Closing the Training Gap in Clinical Research

September 4, 2014
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate

Pediatric Clinical Trials: Special Considerations and Requirements

September 8, 2014
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate

Global Clinical Trials

September 10, 2014
Boston, MA

Disruptive Innovations

September 11 - 12, 2014
Boston, MA
See All Events

LIFE SCIENCE SUPPLEMENTS

2014 -Trends In Clinical Research Outsourcing 2014 CMO Pharma Development & Manufacturing
 
Life Science Leader’s readership of pharmaceutical and biopharmaceutical executives have told us about their struggles in efficiently vetting potential CMO and CRO partners. In response to this input, Life Science Leader developed the Leadership Awards based on the industry leading research conducted by Nice Insight.
2014 CRO Leadership Awards 2013 CMO Leadership Awards
   
   
 

 

     
     
Newsletter Signup
Get the latest industry news, insights, and analysis delivered to your inbox.
Join your peers

VIEW THE DIGITAL EDITION